Journal: Synthetic and Systems Biotechnology

Article Title: Engineering Escherichia coli for robust Co-utilization of glucose and xylose enables high-titer succinate production from lignocellulosic hydrolysates

doi: 10.1016/j.synbio.2026.01.006

Figure Lengend Snippet: Investigation of xylose transport and PTS modification for succinate production. (A) Schematic representation of glucose and xylose transport routes in different E. coli strains, highlighting the key transporters and metabolic nodes influencing carbon flux; (B) Intracellular ATP levels in strains C600, MG1655, and BW25113 during aerobic growth on xylose; (C) Comparison of succinate and by-product accumulation between the parental strain C600 and engineered strain ESC2 under anaerobic conditions; (D) Fermentation performance of PTS-modified strain ESC3, showing sugar utilization, biomass generation, and succinate production; (E–F) Growth profiles of engineered ESC3 derivatives in defined medium with xylose (E) or glucose–xylose mixtures (F). All experimental data were performed in triplicate, and error bars represent the standard deviation. Statistical analysis was performed using a two-tailed Student's t -test (∗∗p < 0.01, ∗∗∗p < 0.001).

Article Snippet: In this study, we systematically engineered E. coli C600 (ATCC 23724) [ ], a strain with efficient and low-energy xylose transport, as the chassis for succinate production from lignocellulosic sugars.

Techniques: Modification, Comparison, Standard Deviation, Two Tailed Test

Journal: Synthetic and Systems Biotechnology

Article Title: Engineering Escherichia coli for robust Co-utilization of glucose and xylose enables high-titer succinate production from lignocellulosic hydrolysates

doi: 10.1016/j.synbio.2026.01.006

Figure Lengend Snippet: Construction of a succinate-producing strain from C600. (A) Metabolic map illustrating targeted knockouts ( ldhA , pflB , ptsG , adhE and pta-ackA ) and expression/integration of pck to redirect flux toward succinate; (B) Two-stage fermentation scheme comprising aerobic growth using shaking flasks and followed by anaerobic production in serum bottles; (C–D) Succinate fermentation of six engineered strains cultured on xylose (C) or glucose–xylose mixtures (D). All experimental data were performed in triplicate, and error bars represent the standard deviation.

Article Snippet: In this study, we systematically engineered E. coli C600 (ATCC 23724) [ ], a strain with efficient and low-energy xylose transport, as the chassis for succinate production from lignocellulosic sugars.

Techniques: Expressing, Cell Culture, Standard Deviation

Journal: Synthetic and Systems Biotechnology

Article Title: Engineering Escherichia coli for robust Co-utilization of glucose and xylose enables high-titer succinate production from lignocellulosic hydrolysates

doi: 10.1016/j.synbio.2026.01.006

Figure Lengend Snippet: Evaluation of exogenous xylose utilization pathways and library-based strain selection. (A) Schematic comparison of the endogenous XI pathway with the Dahms and Weimberg pathways; (B) Design of pathway plasmid libraries and RBS variants controlling expression of key genes for Dahms and Weimberg pathways. The Weimberg library plasmid carries XylA , XylX , and XylB from C. crescentus , while the Dahms library plasmid contains XylB from C. crescentus . The helper plasmid harbors xylC from C. crescentus and the endogenous yjhG from E. coli . RBS sequences were designed with 32 mutations, enabling gene expression levels ranging from 4 to 57,523 au; (C) Growth and succinate production of four representative ESC7 derivatives (ESC7-W1, ESC7-W2, ESC7-D1, ESC7-D2), which were randomly selected from the Weimberg (W1, W2) or Dahms (D1, D2) pathway libraries, compared with ESC6 (XI pathway); (D) Fermentation performance of the same four ESC7 clones carrying the helper plasmid (harboring XylC and yjhG ), compared with ESC6; (E) Validation of pathway combinations in the ESC6 background using the same four representative plasmids, integrating XI with Dahms/Weimberg routes and help plasmid; (F) Screening of library colonies identified six optimal variants, which were reconstructed in ESC6 and evaluated for succinate production from glucose–xylose mixtures. All experimental data were performed in triplicate, and error bars represent the standard deviation. Statistical analysis was performed using a two-tailed Student's t -test (∗∗∗ p < 0.001).

Article Snippet: In this study, we systematically engineered E. coli C600 (ATCC 23724) [ ], a strain with efficient and low-energy xylose transport, as the chassis for succinate production from lignocellulosic sugars.

Techniques: Selection, Comparison, Plasmid Preparation, Expressing, Gene Expression, Clone Assay, Biomarker Discovery, Standard Deviation, Two Tailed Test

Journal: Comparative Immunology Reports

Article Title: The synthetic peptide GATR-3 shows significant antibacterial and biofilm-inhibition activity against shellfish- and oyster-associated bacteria Vibrio vulnificus and Vibrio parahaemolyticus

doi: 10.1016/j.cirep.2025.200266

Figure Lengend Snippet: EC 50 results for Vibrio strains against GATR-3, LL-37-NH 2 , and Mastoparan-AF-NH 2 peptides. Vibrio vulnificus MO6 EC 50 results against A. GATR-3, B. LL-37-NH 2 , and C. Mastoparan-AF-NH 2 peptides. Vibrio vulnificus JY1701 EC 50 results against D. GATR-3, E. LL-37-NH 2 , and F. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus NY477 EC 50 results against G. GATR-3, H. LL-37-NH 2 , and I. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus SAK11 EC 50 results against J. GATR-3, K. LL-37-NH 2 , and L. Mastoparan-AF-NH 2 peptides. Escherichia coli EC 50 results against M. GATR-3, N. LL-37-NH 2 , and O. Mastoparan-AF-NH 2 peptides.

Article Snippet: Against the control strain E. coli ATCC 25922, GATR-3 was extremely potent, with an EC50 of 4.44 × 10−5 μM (1.27 × 10−4 μg/mL), confirming its broad-spectrum and potent efficacy.

Techniques:

Journal: Comparative Immunology Reports

Article Title: The synthetic peptide GATR-3 shows significant antibacterial and biofilm-inhibition activity against shellfish- and oyster-associated bacteria Vibrio vulnificus and Vibrio parahaemolyticus

doi: 10.1016/j.cirep.2025.200266

Figure Lengend Snippet: Biofilm Formation of Vibrio isolates and E. coli . Quantitative comparison of biofilm formation among Vibrio isolates and E. coli after 24 h incubation. Biofilm biomass was determined by crystal violet staining and measurement of OD₆₀₀. V. vulnificus MO6 and V. parahaemolyticus NY477 exhibited the highest biofilm-forming capacities.

Article Snippet: Against the control strain E. coli ATCC 25922, GATR-3 was extremely potent, with an EC50 of 4.44 × 10−5 μM (1.27 × 10−4 μg/mL), confirming its broad-spectrum and potent efficacy.

Techniques: Comparison, Incubation, Staining

Journal: One Health

Article Title: Prevalence and risk factors of antimicrobial resistance in Staphylococcus spp. and Escherichia coli in fruit bats at high-risk human-wildlife interfaces in Bangladesh

doi: 10.1016/j.onehlt.2025.101300

Figure Lengend Snippet: Prevalence of E. coli and Staphylococcus spp. in feces in fruit bat species of Bangladesh ( n = 369). Numbers within the bars represent culture positive isolates of bacteria detected in the respective bat species.

Article Snippet: The results of susceptibility testing were interpreted following the Clinical Laboratory and Standards Institute (CLSI) guideline and the manufacturer's (OXOID, UK) interpretation criteria using the E. coli ATCC 25922 and Staphylococcus aureus ATCC 25923 as a reference strain for quality control ([ ]; Oxoid [ ]) to interpret the zone of inhibition.

Techniques: Bacteria

Journal: One Health

Article Title: Prevalence and risk factors of antimicrobial resistance in Staphylococcus spp. and Escherichia coli in fruit bats at high-risk human-wildlife interfaces in Bangladesh

doi: 10.1016/j.onehlt.2025.101300

Figure Lengend Snippet: AMR pattern of E. coli in bats. Note: AMX = Amoxicillin, AMP = Ampicillin, CFM = Cefixime, CFP=Cefepime, CTX = Cefotaxime, CRO=Ceftriaxone.

Article Snippet: The results of susceptibility testing were interpreted following the Clinical Laboratory and Standards Institute (CLSI) guideline and the manufacturer's (OXOID, UK) interpretation criteria using the E. coli ATCC 25922 and Staphylococcus aureus ATCC 25923 as a reference strain for quality control ([ ]; Oxoid [ ]) to interpret the zone of inhibition.

Techniques: